Search
Research
Towards the establishment of the PREVAIL Centre, a Centre for PREcision in VAccine ImpLmentation at The Kids Research Institute AustraliaPat Tom Holt Snelling PhD, DSc, FRCPath, FRCPI, FAA BMBS DTMH GDipClinEpid PhD FRACP Emeritus Honorary Researcher Head, Infectious Disease
Research
Upskilling Service Providers on LGBTQA+ Suicide PreventionThis project aims to implement LGBTQA+ youth suicide prevention guidelines in clinical and community services in Western Australia.
Research
Using PARP inhibitors to radiosensitise medulloblastomaRaelene Nick Endersby Gottardo BSc (Hons) PhD MBChB FRACP PhD Brainchild Fellow; Co-Head, Brain Tumour Research Co-Head, Brain Tumour Research
Research
UVR exposure, Vitamin D and type 1 diabetesLiz Prue Davis Hart MBBS FRACP PhD BSc (Hons) MSc PhD Theme Head, Chronic & Severe Diseases; Clinical Lead, Diabetes and Obesity Research Honorary
Research
Virtual Reality Integrated Social Recovery (VISOR)As well as specific symptom clusters, psychosis effects important non-symptom domains including social cognition and social-occupational functioning.
Research
WA Department of Health Merit Awards - Project - Improving Aboriginal health disparities: the influence of education, child protection and justice systems over time and across generationsFrancis Sarah Mitrou Johnson BEc BA, PostGradDip; PhD Program Head, Population Health, and Team Head, Human Development and Community Wellbeing
Research
Western Australian Aboriginal Children’s Outcomes – The Impact of Parent’s Mental HealthRebecca Fiona Carrington Glauert Stanley Shepherd BPsych (Hons) PhD FAA FASSA MSc MD FFPHM FAFPHM FRACP FRANZCOG HonDSc HonDUniv HonFRACGP HonMD
Research
What risk does underlying trimethoprim resistance pose for the development of cotrimoxazole-resistant skin infectionsTim Barnett PhD Head, Strep A Pathogenesis and Diagnostics timothy.barnett@thekids.org.au Head, Strep A Pathogenesis and Diagnostics Tim has worked
Research
A Phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK's meningococcal Group B and combined ABCWY vaccines when administered to healthy adolescents and young adults (Quintet)Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Research
A randomized, controlled, observer-blind, phase 1/2a study to evaluate the safety, reactogenicity, and immunogenicity of Ad26.RSV.preF in RSV-seronegative toddlers 12 to 24 months of ageJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical